PMID: 6950419Dec 1, 1981Paper

Calcitonin: regional distribution of the hormone and its binding sites in the human brain and pituitary

Proceedings of the National Academy of Sciences of the United States of America
J A FischerJ B Martin


Immunoreactive calcitonin (CT), indistinguishable from human CT-(1-32) and its sulfoxide, has been identified in extracts of the hypothalamus, the pituitary, and the thyroid obtained from human subjects at autopsy. DCT concentrations were highest in a region encompassing the posterior hypothalamus, the median eminence, and the pituitary; intermediate in the substantia nigra, the anterior hypothalamus, the globus pallidus, and the inferior colliculus; and low in the caudate nucleus, the hippocampus, the amygdala, and the cerebral and cerebellar cortices. Specific CT binding measured with 125I-labeled salmon CT was highest in homogenates of the posterior hypothalamus and the median eminence, shown to contain the highest concentrations of endogenous CT in the brain; CT binding was less than 12% of hypothalamic binding in all of the other regions of the brain examined and was negligible in the pituitary. Half-maximal binding was achieved with 0.1 nM nonradioactive salmon CT-(1-32), and the binding was directed to structural or conformational sites, or both, in the COOH-terminal half of salmon CT. The rank order of the inhibition of the binding by CT from different species and analogues of the human hormone was the same as in recept...Continue Reading


Aug 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J MoranJ A Fischer
Jan 1, 1979·Journal of Immunological Methods·B D Catherwood, L J Deftos
Aug 1, 1978·The Journal of Clinical Endocrinology and Metabolism·L J DeftosR Y Moore
Aug 1, 1979·Annals of Internal Medicine·H Heath, A J Edis
Nov 16, 1979·Science·W J FreedR J Wyatt
Oct 1, 1979·Life Sciences·Y IwasakiT Fujita
Dec 1, 1979·Acta Endocrinologica·K L BeckerO L Silva
Mar 15, 1975·Experientia·A PecileV R Olgiati
Aug 1, 1973·The Journal of Clinical Endocrinology and Metabolism·E F VoelkelR J Wurtman
Feb 15, 1972·Experientia·M S ZileliN Adalar
May 1, 1981·Endocrinology·A J Rizzo, D Goltzman
May 15, 1980·Experientia·K L BeckerO L Silva
Jan 1, 1981·Neuropharmacology·M YamamotoH Maeno
May 11, 1981·Brain Research·F Galan GalanI MacIntyre
Feb 1, 1981·Japanese Journal of Pharmacology·H NakamutaR Schlueter
Jul 1, 1981·Acta Endocrinologica·F Galan GalanI MacIntyre
Apr 1, 1980·The Journal of Clinical Endocrinology and Metabolism·D M PavlinacL J Deftos
Aug 4, 1980·Brain Research·K L BeckerC F Moore

❮ Previous
Next ❯


Oct 1, 1994·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·P S WangC H Chien
Jan 1, 1992·Journal of Neural Transmission. General Section·Z ObermanL Laurian
Jan 1, 1992·International Journal of Legal Medicine·F TagliaroM Marigo
Jul 15, 1987·Experientia·J M Palacios, M M Dietl
Jan 1, 1992·Psychopharmacology·R PietrowskyJ Born
Jan 1, 1986·Acta diabetologica latina·S SgambatoP Tesauro
Dec 12, 2007·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·C H ChesnutL Mindeholm
Mar 19, 1984·Brain Research·G ClementiU Scapagnini
Jul 14, 1989·Clinica Chimica Acta; International Journal of Clinical Chemistry·R CatalánJ M Castellanos
Feb 18, 1986·European Journal of Pharmacology·M J TweryC W Cooper
May 1, 1986·Pharmacology, Biochemistry, and Behavior·M J TweryC W Cooper
Jan 1, 1985·Neuroscience and Biobehavioral Reviews·R Quirion, P Gaudreau
Jan 1, 1996·Neuroscience and Biobehavioral Reviews·M G Tordoff
Jan 1, 1992·Pharmacology & Therapeutics·D R Poyner
Feb 4, 1990·Regulatory Peptides·M Fouchereau-PeronM S Moukhtar
Jan 1, 1988·Neurochemistry International·P M SextonF A Mendelsohn
Jun 1, 1984·Molecular and Cellular Endocrinology·F A TschoppJ A Fischer
Sep 18, 1996·Molecular and Cellular Endocrinology·K S SelanderH K Väänänen
Mar 23, 1984·Neuroscience Letters·S SpampinatoS Ferri
Oct 10, 1985·Neuroscience Letters·U GerberW Schaffner
May 18, 2005·The International Journal of Biochemistry & Cell Biology·Steven S-S WangDawn L Rymer
Jun 19, 1998·Pharmacology, Biochemistry, and Behavior·K ShibataH Sagai
Oct 16, 2003·Placenta·M Cavagna, J C Mantese
Mar 9, 2000·Regulatory Peptides·G Rodríguez de Lores Arnaiz, P G Schneider

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.